All In Biotech

Drug Trial Radar · NCT05137314

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

A Phase 1b Open-Label, Dose-Escalating Study to Evaluate the Safety and Tolerability of PLG0206 in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

Last checked: Nov 19, 2026Latest source record: May 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

14

Actual

Start

Mar 31, 2022

Primary completion

Mar 19, 2024

Study completion Mar 19, 2024

Sponsor

Lead sponsor
PeptilogicsIndustry
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority; Wellcome Trust
First posted
Nov 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about the safety and effects of PLG0206 for treating periprosthetic joint infections (PJI) in conjunction with the DAIR (debridement, antibiotics and implant retention) surgical procedure for patients with periprosthetic joint infections (PJI) after total knee arthroplasty (TKA) .

Conditions

  • Joint Infection

Interventions

  • PLG0206Drug

    PLG0206 is an engineered antibacterial peptide (EAP)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage of treatment emergent AEsTime frame: approximately 1 year

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford Hospital

    Palo Alto, California

  • Gulfcoast Research

    Sarasota, Florida

  • LifeBridge

    Baltimore, Maryland

  • Brigham & Women's Hospital

    Boston, Massachusetts

  • NYU Langone Orthopedic Hospital

    New York, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Ohio State University

    Columbus, Ohio

  • Rothman

    Philadelphia, Pennsylvania

  • Memorial Hermann Hospital

    Houston, Texas

  • Michael E. DeBakey VA Medical Center

    Houston, Texas

  • University of Utah Orthopaedic Center

    Salt Lake City, Utah

  • WVU

    Morgantown, West Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.